Latest in Vaccines & Immunology

89 words

Fc-Free CLDN18.2 × CD3 Antibody AHT-102 Shrinks Gastric Tumors in Mice

A new Fc-free CLDN18.2 × CD3 bispecific antibody called AHT-102 showed dose-dependent tumor suppression, tumor-selective tissue distribution, and no systemic immunotoxicity in preclinical mouse models. AHT-102 was engineered specifically to address these limitations through two structural choices: the removal of the Fc region…

Vaccines & Immunology

mRNA platforms, boosters, monoclonals, and immune‑system science.

  • 18 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.